REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Globalpharmaceutica S.A. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Globalpharmaceutica S.A. Profile Updated: December 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Globalpharmaceutica S.A. is based in Colombia, with the head office in Sincelejo. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on April 26, 2004. There was a net sales revenue drop of 22.32% reported in Globalpharmaceutica S.A.’s latest financial highlights for 2023. During that time, Globalpharmaceutica S.A.’s total assets decreased by 20.13%. In 2023, Globalpharmaceutica S.A.’s net profit margin decreased by 1.68%.

Headquarters
Calle 39 # 4 F 83 Bodega 5 Mza 1 Parque Industrial
Sincelejo; Sucre;

Contact Details: Purchase the Globalpharmaceutica S.A. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Globalpharmaceutica S.A. report to view the information.
Incorporation Date:
April 26, 2004
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Deputy Member of the Board of Directors
Purchase this report to view the information.
Deputy Member of the Board of Directors
Company Performance
Financial values in the chart are available after Globalpharmaceutica S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-22.32%▼
Total operating revenue
-22.25%▼
Operating profit (EBIT)
-17.77%▼
EBITDA
-16.83%▼
Net Profit (Loss) for the Period
-44.73%▼
Total assets
-20.13%▼
Total equity
42.13%▲
Operating Profit Margin (ROS)
0.53%▲
Net Profit Margin
-1.68%▼
Return on Equity (ROE)
-46.59%▼
Debt to Equity Ratio
14.55%▲
Quick Ratio
0.32%▲
Cash Ratio
0.03%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo